Search results
GSK buys full rights to COVID, influenza vaccines from CureVac - ET HealthWorld | Pharma
The Economic Times· 1 day agoGSK said it will pay CureVac 400 million euros ($429.44 million) upfront and up to an additional...
GSK said it will pay CureVac 400 million euros ($429.44 million) upfront and up to an additional...